Semnur Pharmaceuticals, Inc. (SMNR)
0.55
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Semnur Pharmaceuticals Total Liabilities (Quarterly) : 31.62M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.62M |
| March 31, 2026 | 27.30M |
| December 31, 2025 | 22.10M |
| September 30, 2025 | 15.37M |
| June 30, 2025 | 11.16M |
| March 31, 2025 | 10.74M |
| December 31, 2024 | 49.47M |
| September 30, 2024 | 9.482M |
| June 30, 2024 | 9.207M |
| Date | Value |
|---|---|
| March 31, 2024 | 8.887M |
| December 31, 2023 | 8.492M |
| September 30, 2023 | 7.968M |
| June 30, 2023 | 6.641M |
| March 31, 2023 | 5.866M |
| December 31, 2022 | 4.179M |
| September 30, 2022 | 2.978M |
| June 30, 2022 | 3.050M |
| March 31, 2022 | 0.4282M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Scilex Holding Co. | 564.05M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.943M |
| Shareholders Equity (Quarterly) | -29.67M |
| Debt to Equity Ratio | -0.7768 |
| Current Ratio | 0.1118 |
| Net Debt Paydown Yield | -3.50% |